Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$12.68 - $17.79 $387,488 - $543,644
-30,559 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$12.95 - $15.41 $395,739 - $470,914
30,559 New
30,559 $422,000
Q4 2020

Feb 16, 2021

SELL
$16.56 - $18.94 $15,367 - $17,576
-928 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$17.41 - $19.89 $6,006 - $6,862
345 Added 59.18%
928 $17,000
Q2 2020

Aug 14, 2020

BUY
$14.43 - $19.16 $7,965 - $10,576
552 Added 1780.65%
583 $10,000
Q4 2018

Feb 14, 2019

BUY
$8.65 - $16.28 $268 - $504
31 New
31 $0

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $71.5M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.